Sun Pharma posts net profit of ₹ 996 crores at Q2FY19
In H1FY19,the company's sales / income from operations was at ₹ 13,985 crores
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Rockwell Automation and PTC collaborate
The collaboration will help to drive digital transformation across industrial enterprises
Novo Nordisk Education Foundation launches ‘1000-Day Challenge’ on diabetes
The challenge intends to improve awareness and education amongst 150,000 practitioners and 10,000 paramedics through over 6,000…
Aurobindo inks pact with Advent Pharmaceuticals for $12.5 million
To acquire Australian pharma firm's product
Ananth Kumar, Parliamentary Affairs and Chemicals and Fertilizers Minister, passes away
Kumar, 59, was suffering from lung cancer
Suven Life gets product patents from Australia, Hong Kong
The patents are valid till 2036 and 2033
Lupin launches generic Atovaquone oral suspension USP in the US
The drug is indicated for the prevention of Pneumocystis jirovecii pneuomonia (PCP) in adults
InvaGen in agreement with Avenue Therapeutics for specialty hospital business in the US
Upon first stage closing, InvaGen Pharmaceuticals, a Cipla subsidiary, to acquire shares representing a 33.3 per cent stake in…
DRL’s Duvvada unit undergoes German regulator’s follow-on-audit
The facility is considered compliant and the EU-GMP certification continues to remain active with one specific exclusion of a new…
Flexible biopatch can deliver precise drug dosage
Researchers hope to develop the patch's functionality to act as an external skin patch, lowering the pain, invasiveness and…
Zydus Cadila gets US FDA nod for anti-fungal ointment
The drug will be manufactured at the group's Topical manufacturing facility at Ahmedabad
Cipla receives final approval for generic version of Roche’s Valcyte
The drug is indicated for use in the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome and prevention…
Wockhardt Q2 net loss widens to ₹ 23 crore
The company, which plans to raise up to ₹ 1,800 crore through private placement of non-convertible debentures, had reported a…
Novartis division Sandoz recalls one lot of blood pressure drug
The drug is made by China’s Zhejiang Huahai Pharmaceutical
Mylan and Theravance’s COPD treatment gets FDA approval
The treatment, Yupelri, is a once-daily inhalable solution to be used by patients of COPD
Glenmark to launch trial in solid tumours for its CD38xCD3 bispecific antibody GBR 1342
GBR 1342 is one of three investigational immuno-oncology agents based on Glenmark’s proprietary BEAT platform
Strides’ subsidiary inks pact with SUDA Pharmaceuticals for migraine drug
Under the terms of agreement, SUDA will receive an upfront cash payment of $ 0.4 million and a further payment of $ 0.6 million on…
IIT Roorkee researchers develop carbon nanomaterials for detection and destruction of cancer cells
With these promising observations, Dr Gopinath and his team are planning next stage animal studies for further evaluation of these…
Some factors have a greater impact on heart attack risk in women than they do in men: The BMJ
High blood pressure, smoking and diabetes increase heart attack risk more in women than in men
Lilly says diabetes drug Trulicity reduces heart risks in trial
The company did not provide any details on the magnitude of risk reduction seen in the so-called outcomes trial